Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
3.70 Down 0.21(5.37%) 3:59PM EDT
|After Hours : 3.82 Up 0.12 (3.24%) 5:18PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
OXBTNVSPFERHHBYIndustry
Market Cap:104.00M210.93B183.07B246.82BN/A
Employees:N/A135,00077,70085,080N/A
Qtrly Rev Growth (yoy):N/A0.03-0.020.01N/A
Revenue (ttm): 288.73K59.33B50.33B53.90BN/A
Gross Margin (ttm):0.550.660.820.75N/A
EBITDA (ttm):-16.46M16.66B21.88B20.85BN/A
Operating Margin (ttm): -57.530.200.320.34N/A
Net Income (ttm):-25.35M9.22B10.37B11.90BN/A
EPS (ttm):-3.673.923.221.80N/A
P/E (ttm):N/A22.188.9120.21N/A
PEG (5 yr expected):N/A2.173.212.77N/A
P/S (ttm):380.633.623.714.64N/A
 
NVS = Novartis AG
PFE = Pfizer Inc.
RHHBY = Roche Holding AG

 
News on Direct Competitors 

Currency in USD.